Get started Log in

CALA — Calithera Biosciences Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Brief: Calithera Biosciences Prices Public Offering Of 5 Mln Shares Of Common Stock
16/04/2020 05:20
Calithera Biosciences falls on stock offering plans
15/04/2020 21:44
Brief: Calithera Biosciences Inc Reports Commencement Of Underwritten Public Offering Of Common Stock
15/04/2020 21:10
U.S. RESEARCH ROUNDUP-Campbell Soup, General Mills, TCP Pipelines
15/04/2020 08:43
Brief: Calithera Biosciences Expects To Delay Enrollment Of First Patient In Randomized Keapsake Trial Until Q3
14/04/2020 12:32
NASDAQ RESUMED AT 04:06 PM
13/03/2020 21:06
NASDAQ RESUMED AT 03:47 PM
13/03/2020 20:47
NASDAQ RESUMED AT 03:03 PM
13/03/2020 20:03
NASDAQ RESUMED AT 02:53 PM
13/03/2020 19:53
NASDAQ RESUMED AT 02:17 PM
13/03/2020 19:17
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 08:43 AM
13/03/2020 13:43
Nasdaq Trade Halt Market Wide Circuit Breaker Halt: LEVEL 1 AT 08:44 AM
09/03/2020 13:44
Brief: Calithera Biosciences Expects To Utilize Cash And Investments Between $75 And $85 Mln In 2020
13/01/2020 12:42
Brief: Primecap Management Company Reports 15% Passive Stake In Calithera Biosciences As Of Dec 31, 2019
10/01/2020 17:41
Brief: Calithera Biosciences Says May Offer And Sell Shares Of Common Stock Of Up To $50 Million
06/12/2019 22:24
Brief: Calithera Biosciences Reports Q3 Loss Per Share $0.38
12/11/2019 21:21
Brief: Calithera Biosciences Says Cantata Trial Top-Line Results Expected In H2 Of 2020
03/10/2019 12:05
Brief: Calithera Biosciences Says Q2 Loss Per Share $0.58
08/08/2019 22:17
Brief: Calithera Biosciences Initiates Phase 1/2 Trial Of Telaglenastat
02/07/2019 13:58
U.S. STOCKS ON THE MOVE-QuickLogic, PG&E, Banks, Jabil
19/06/2019 18:50